Pizzocaro
Roberta Pizzocaro, Rodano IT
Patent application number | Description | Published |
---|---|---|
20090275766 | PROCESS FOR THE PREPARATION OF TIGECYCLINE IN THE AMORPHOUS FORM - The invention relates to processes for the preparation of tigecycline (I): | 11-05-2009 |
20100179180 | CRYSTALLINE IRINOTECAN HYDROCHLORIDE AND METHODS FOR ITS PREPARATION - Disclosed is a crystalline form of irinotecan hydrochloride (I) and processes for the preparation thereof from crude irinotecan hydrochloride or another polymorphic form of irinotecan. Said crystalline form is particularly suitable for industrial use, because it is easily filtered and possesses characteristics of high stability and purity. | 07-15-2010 |
Roberta Pizzocaro, Milano IL
Patent application number | Description | Published |
---|---|---|
20100137580 | Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained - A process is described which enables Rifaximin in a completely amorphous form to be obtained. Said process comprises the steps of dissolving crude Rifaximin in absolute ethanol while hot and then collecting after precipitation by cooling the title compound under amorphous form. | 06-03-2010 |
Roberta Pizzocaro, Garbagnate IT
Patent application number | Description | Published |
---|---|---|
20090192184 | Crystalline Polymorphs of Topotecan Hydrochloride and Methods for the Preparation Thereof - The invention relates to two novel crystalline form of Topotecan hydrochloride (Ia) | 07-30-2009 |
Roberta Pizzocaro, Mulazzano IT
Patent application number | Description | Published |
---|---|---|
20090156863 | ATOMOXETINE HYDROCHLORIDE PURE CRYSTALLINE FORM - The present invention discloses a process for the preparation of atomoxetine hydrochloride in a pure crystalline form, characterised by an XRPD spectrum as in FIG. | 06-18-2009 |
Roberta Pizzocaro, Garbagnate Milanese IT
Patent application number | Description | Published |
---|---|---|
20080287693 | Process for the Preparation of 1-Naphthol Mixed Ethers and Intermediates of Crystalline Forms of (+) and (-)-Duloxetine - The invention relates to a process for the preparation of duloxetine (1a), comprising the reaction between 1-fluoronaphthalene and 3-N,N-dimethylamino-1-(2-thienyl)-propan-1-ol in the presence of 1,3-dimethyl-2-oxo-hexahydropyrimidine (DMPU) as the solvent; a method for the identification of duloxetine enantiomers and for the determination of its optical purity is also disclosed. | 11-20-2008 |
20090118538 | PROCESS FOR PREPARATION OF PURE ACITRETIN - Processes and systems for the preparation of substantially pure acitretin based on reacting crude acitretin and an amine in presence of a suitable solvent to provide a salt that is then reacted with an organic acid to obtain substantially pure acitretin. | 05-07-2009 |
Roberta Pizzocaro, Rodano (mi) IT
Patent application number | Description | Published |
---|---|---|
20110230541 | PROCESS FOR THE PREPARATION OF ROTIGOTINE - A process for the preparation of Rotigotine (I) and of pharmaceutically acceptable salts thereof, which comprises the reductive amination of an amine of formula 6 with the 2-thienylacetic acid-sodium boron hydride complex and which makes use of hydrobromide 5 as an intermediate (II) The process is advantageous from the industrial point of view in that it allows to obtain Rotigotine with high enantiomeric purity starting from optically active 5,6,7,8-tetrahydro-6-(S)-N-propylamino-1-methoxy-naphthalene (2), avoiding the use of dangerous reactives, the need for difficult chromatographic separation or the formation of by-products. Furthermore, two novel crystalline forms are disclosed. | 09-22-2011 |
20130317255 | PROCESS FOR THE PREPARATION OF ROTIGOTINE - A process for the preparation of Rotigotine (1) | 11-28-2013 |
20130345283 | PROCESS FOR THE PREPARATION OF ROTIGOTINE - A process for the preparation of Rotigotine (1) | 12-26-2013 |
Roberta Pizzocaro, Milano IT
Patent application number | Description | Published |
---|---|---|
20130338355 | PROCESS FOR PREPARING AMORPHOUS RIFAXMIN AND THE AMORPHOUS RIFAXIMIN THUS OBTAINED - A process is described which enables Rifaximin in a completely amorphous form to be obtained. Said process comprises the steps of dissolving crude Rifaximin in absolute ethanol while hot and then collecting after precipitation by—cooling the title compound under amorphous form. | 12-19-2013 |
20150011750 | PROCESS FOR PREPARING AMORPHOUS RIFAXMIN AND THE AMORPHOUS RIFAXIMIN THUS OBTAINED - A process is described which enables Rifaximin in a completely amorphous form to be obtained. Said process comprises the steps of dissolving crude Rifaximin in absolute ethanol while hot and then collecting after precipitation by—cooling the title compound under amorphous form. | 01-08-2015 |